NCT01485965View on ClinicalTrials.gov

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Huntington's Disease
Interventions
DRUG

SEN0014196

100 mg, immediate release tablets, once daily administration

Trial Locations (7)

14627

University of Rochester, Rocherster

63110

Washington University, St Louis

77030

Baylor College of Medicine, Houston

95655

University of California Davis Medical Center, Sacramento

92037-0706

University of California San Diego, La Jolla

27157-1078

Wake Forest School of Medicine, Winston-Salem

75390-8527

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Siena Biotech S.p.A.

INDUSTRY

NCT01485965 - A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease | Biotech Hunter | Biotech Hunter